Tsvetelina Eftimova

Tsvetelina Eftimova

Auto-generated profile, based on publicly available information

Tsvetelina Eftimova

Department of Dialysis, University Hospital "Saint Marina" – Pleven, Bulgaria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2026 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
TSTatyana Simeonova
Tatyana Simeonova
BIBorislav Ignatov
Borislav Ignatov
ATAnna Tolekova
Anna Tolekova
TETsvetelina Eftimova
Tsvetelina Eftimova
Alexander Bozhidarov BlazhevAlexander Bozhidarov Blazhev
Alexander Bozhidarov Blazhev
Krasimir KostovKrasimir Kostov
Krasimir Kostov
Vitamin K2 plays a key role in calcium homeostasis through activation of VKDP, including matrix Gla protein, a potent inhibitor of vascular calcification. Impaired vitamin K2 status results in increased circulating levels of inactive dephosphorylated uncarboxylated MGP (dp-ucMGP), which serves as a marker for vitamin K2 deficiency. CKD patients are at particularly high risk of vitamin K2 deficiency and its related complications. Purpose: To assess vitamin K2 status indirectly by measuring plasma dp-ucMGP levels in patients with pre-dialysis CKD. Material/Methods: This cross-sectional study included 71 adult Caucasian patients with pre-dialysis CKD stages G1–G4, classified according to KDIGO criteria. Participants were divided into three groups based on estimated glomerular filtration rate (eGFR). Serum creatinine, calcium, inorganic phosphate, and plasma dp-ucMGP levels were measured. Statistical analyses were performed using appropriate parametric and non-parametric tests. Results: Significant differences were observed among the groups in age, renal function parameters, serum calcium, and phosphate levels (p < 0.05). Plasma dp-ucMGP concentrations did not differ significantly between CKD stages. However, when compared with recalculated reference values reported in the literature, dp-ucMGP levels in all groups were elevated, suggesting functional vitamin K2 deficiency. Sex-specific analysis revealed significantly higher dp-ucMGP levels in females with preserved to moderately reduced renal function, while no sex-related differences were observed in advanced CKD. Conclusion: Patients with pre-dialysis CKD demonstrated poor vitamin K2 status, as reflected by elevated dp-ucMGP levels. These findings support growing evidence that vitamin K2 deficiency is common and clinically relevant in the earlytages of CKD.

2 May 2025 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
TSTatyana Simeonova
Tatyana Simeonova
BIBorislav Ignatov
Borislav Ignatov
TETsvetelina Eftimova
Tsvetelina Eftimova
Krasimir KostovKrasimir Kostov
Krasimir Kostov
Vitamin K2 deficiency is associated with arterial calcification, which is a significant problem in patients with chronic kidney disease. It occurs more rapidly and earlier and appears to be an independent risk factor for higher morbidity and mortality. The ucMGP is considered to be a biomarker for indirect measurement of vitamin K2 status. Purpose: Our study aimed to measure ucMGP levels in patients at different stages of CKD and to evaluate its potential role as a biomarker of vitamin K2 status. Material/Methods: Sixty-seven patients aged between 31 – 87 years took part in the study. They were divided into groups according to glomerular filtration rate: Group I, with GFR ≥90 ml/min, Group II, with GFR 89 – 45 ml/min, Group III, with GFR 44 – 15 ml/min. Venous blood was tested for calcium, phosphate, creatinine and ucMGP. Results: Serum calcium and phosphate levels were within the reference ranges across all groups. Phosphate levels showed a progressive increase, with significantly lower levels in Group III. Mean ucMGP levels decreased from Group I to Group III, although these differences did not reach statistical significance. In Group I, women had significantly lower ucMGP concentrations compared to men. The incidence of CVD increased significantly with the progression of renal failure. Participants with CVD in Group I demonstrated significantly higher ucMGP concentrations compared to Group III. Conclusions: Uncarboxylated MGP can provide information about vitamin K2 and its carboxylation, but it is not a specific or reliable marker of vitamin K2 status.

17 March 2025 in Journal of Biomedical and Clinical Research
Verified
Journal Article
Open access
PDF file
BIBorislav Ignatov
Borislav Ignatov
TSTatyana Simeonova
Tatyana Simeonova
TETsvetelina Eftimova
Tsvetelina Eftimova
ADAnelia Dimitrova
Anelia Dimitrova
Krasimir KostovKrasimir Kostov
Krasimir Kostov
Introduction: Chronic kidney disease (CKD) patients are at high risk for cardiovascular disease, largely due to the presence of vascular calcification and its associated complications. Undercarboxylated matrix Gla protein (ucMGP), which inhibits vascular calcification, plays a crucial role in preventing this condition. Aim: Our study aimed to compare ucMGP levels in CKD patients with preserved and reduced renal function and to evaluate its role as a biomarker for cardiovascular risk. Materials and methods: We studied 84 patients with predialysis CKD. They were divided into two groups according to the kidney function: Group I – patients with preserved renal function (GFR ≥ 90 ml/min) and Group II – patients with mild to severely decreased renal function (GFR between 15 and 89 ml/min). Blood samples were analyzed using the Cobas E 311 automated analyzer and the ucMGP levels were measured using an ELISA kit from Abbexa, UK. Results: In Group I, CVD patients had significantly higher inorganic phosphates, blood urea nitrogen and serum creatinine. In Group II, CVD patients had significantly higher ucMGP concentrations. UcMGP levels were associated with age and CVD in Group II and highly correlated with inorganic phosphate and serum creatinine levels in Group I. Conclusions: UcMGP levels show a significant increase in CKD patients with CVD and are strongly connected to various renal function indices, indicating its potential as a biomarker for cardiovascular risk assessment.

6 August 2026 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
BIBorislav Ignatov
Borislav Ignatov
Krasimir KostovKrasimir Kostov
Krasimir Kostov
TETsvetelina Eftimova
Tsvetelina Eftimova
Alexander Bozhidarov BlazhevAlexander Bozhidarov Blazhev
Alexander Bozhidarov Blazhev
TSTatyana Simeonova
Tatyana Simeonova
Chronic kidney disease (CKD) affects over 10% of the global population, posing significant challenges due to its asymptomatic nature in early stages and progressive deterioration of renal function. The identification of reliable biomarkers for early diagnosis and monitoring of disease progression is crucial for improving prognosis and treatment. Neutrophil gelatinase-associated lipocalin (NGAL) is a promising candidate, already validated as a marker for acute kidney injury. Purpose: This study aimed to evaluate the potential of serum NGAL levels as a biomarker for diagnosis and monitoring the progression of CKD. Material/Methods: Seventy-one adult Caucasian patients at CKD stages G1–G4 according to the KDIGO criteria were divided into three groups: Group 1 (eGFR ≥90 mL/min/1.73m²), Group 2 (eGFR 45–89 mL/min/1.73m²), and Group 3 (eGFR 15–44 mL/min/1.73m²). Blood samples were collected and analyzed via standard biochemical and immunological techniques. Serum NGAL levels were measured using ELISA. Results: NGAL levels increased significantly with disease progression and strongly correlated with declining eGFR. Higher NGAL levels were linked to elevated serum creatinine and inflammatory markers, indicating progressive damage to the kidney tissue against the backdrop of persistent systemic inflammation. Conclusions: As a biomarker, NGAL has significant potential for identifying and monitoring kidney damage. Its application in clinical settings could complement and improve existing methods for diagnosing and observing CKD.